ICaPath
Morgantown, US · Founded 2020 · Delaware corporation
Founders & leadership
SN
Steven NorchNamed on SEC filing
BL
Brock LindseyNamed on SEC filing
Reported raises · per SEC filings
Form D private placements$1.1M disclosed across 2 rounds · 2021–2022
▶$650KraisedSep 2022 · 3 investors · BiotechnologyRule 506(b)
▶$650KraisedSep 2022 · 3 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Brock LindseyExecutive Officer, Director
- Steven NorchExecutive Officer
- Offering amount
- $650K
- Amount sold
- $650K
- First sale
- May 2022
- Incorporated
- Corporation, Delaware, 2020
- Federal exemptions
- 06b
▶$500KraisedOct 2021 · 1 investors · BiotechnologyRule 506(b)
▶$500KraisedOct 2021 · 1 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Steven NorchExecutive Officer
- Brock LindseyExecutive Officer, Director, Promoter
- Offering amount
- $800K
- Amount sold
- $500K
- First sale
- Oct 2021
- Incorporated
- Corporation, Delaware, 2020
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- How much funding has ICaPath raised?
- ICaPath has disclosed $1.1M raised across 2 rounds.
- Where is ICaPath headquartered?
- ICaPath is headquartered in Morgantown, US.